In a decision issued yesterday, Judge Theodore D. Chuang of the United States District Court for the District of Maryland ruled in favor of Schulman Bhattacharya’s client, ExeGi Pharma, LLC, holding its competitors Alfasigma USA, Inc. and VSL Pharmaceuticals, Inc. in contempt of the Permanent Injunction entered last year aimed at halting false advertising of the probiotic medical food VSL#3. This is the latest round in the ongoing legal battle over the highly successful, proprietary probiotic formulation invented by Schulman... read more →
Need something for here
Current News
Schulman Bhattacharya, on behalf of its client, Sachs Capital, LLC, filed a Complaint and motion for a temporary restraining order and preliminary injunction in the Circuit Court for Montgomery County, Maryland, seeking to protect Sachs Capital's interests in the proceeds of a $480 million sale of a major national petroleum company. Sachs Capital, and its related entities, invested more than $31 million in the petroleum company and is set to receive a preferred return on its investment as the sale... read more →
Schulman Bhattacharya, on behalf of its client, Dr. Mohsen Mosleh, filed a complaint against Howard University in the United States District Court for the District of Columbia for its violations of the D.C. Human Rights Act. Dr. Mosleh, a tenured professor at Howard University of Iranian descent, asserts claims against the university for its long-standing discrimination against him on the basis of race and national origin and various acts of retaliation against him. On February 27, 2020, Judge Carl J. Nichols... read more →
Schulman Bhattacharya’s bio-tech litigation practice, which helped clients win more than $91 million dollars in trial verdicts over the past three years, has secured another significant victory. This time, Schulman Bhattacharya represented a defendant, renowned pharmaceutical executive Gregg Lapointe, in a case filed in the United States District Court for the District of Maryland. The plaintiff in Washington County Board of Education v. Mallinckrodt Ard Inc., et al., sought to buttress its case by adding Mr. Lapointe as a defendant, alleging... read more →
A famed, foreign investment banker retained Schulman Bhattacharya after a series of third-party providers, including Google, Microsoft, and LinkedIn, received subpoenas demanding production of the bankers’ emails, browsing history, payment details, and other invasive personal and business information. The subpoenas were issued as part of far-reaching discovery in a case currently pending in the United States District Court for the Southern District of New York and sought to drag the banker into the heart of that case. Schulman Bhattacharya faced... read more →
Hormuud Telecom, the largest telecom company in Somalia and the country’s largest employer and taxpayer, has engaged Schulman Bhattacharya to defend its interests in contentious disputes with various U.S.-based media organizations and the United Nations. Commenting on the engagement, Jeremy W. Schulman, the Firm’s Managing Member, stated: “We are pleased to be representing one of the most vital companies in East Africa, helping to protect its legal rights and interests and clearing its name of scurrilous allegations intended to hamper... read more →
Schulman Bhattacharya, LLC is proud to announce the hiring of two new attorneys who will be resident in the Firm’s Washington-area headquarters office. Jamie Karson joins the firm as Of Counsel. Jake Schaller arrives as an Associate. Jamie Karson is the former Chief Executive Officer and Chairman of the Board of Steve Madden Ltd. (NASDAQ: “SHOO”), one of the most iconic footwear brands in the world. During his tenure at the helm of Steve Madden, the company’s market capitalization reached... read more →
On July 23, 2019, Schulman Bhattacharya commenced a class action lawsuit against the U.S. licensor (VSL Pharmaceuticals, Inc.) and distributors (Alfasigma USA, Inc. and Leadiant Biosciences, Inc.) of the VSL#3 probiotic product. Our complaint, which was filed in the United States District Court for the District of Maryland, asserts sixteen cause of action on behalf of a nationwide class of victims who purchased VSL#3 since June 2016, as well as consumers in subclasses in Massachusetts, California, Texas, New Jersey, Michigan,... read more →
In 54 pages of rulings issued this past Friday, June 21, 2019, Judge Theodore D. Chuang of the United States District Court for the District of Maryland found decisively in favor of Schulman Bhattacharya’s clients—Professor Claudio De Simone and ExeGi Pharma, LLC—upholding our $18 million jury verdict from November 2018 and entering a permanent injunction against the current and former distributors of VSL#3, halting their false advertising of the product. The rulings conclude over four years of litigation in which... read more →
In Schulman Bhattacharya’s ongoing battle over the VSL#3 probiotic product, the Firm successfully resolved a contentious dispute between its client, ExeGi Pharma, LLC, and a group of companies in California that were facilitating the processing of online sales transactions for VSL#3. The e-commerce companies in question are Nexternal Solutions, Inc., True Commerce, Inc., and HighJump Software, Inc. Last November, the Firm prevailed before a jury in Maryland federal court and then obtained a judgment holding that the VSL#3 product was... read more →